Cargando…
A Useful and Sustainable Role for N‐of‐1 Trials in the Healthcare Ecosystem
Clinicians and patients often try a treatment for an initial period to inform longer‐term therapeutic decisions. A more rigorous approach involves N‐of‐1 trials. In these single‐patient crossover trials, typically conducted in patients with chronic conditions, individual patients are given candidate...
Autores principales: | Selker, Harry P., Cohen, Theodora, D’Agostino, Ralph B., Dere, Willard H., Ghaemi, S. Nassir, Honig, Peter K., Kaitin, Kenneth I., Kaplan, Heather C., Kravitz, Richard L., Larholt, Kay, McElwee, Newell E., Oye, Kenneth A., Palm, Marisha E., Perfetto, Eleanor, Ramanathan, Chandra, Schmid, Christopher H., Seyfert‐Margolis, Vicki, Trusheim, Mark, Eichler, Hans‐Georg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022728/ https://www.ncbi.nlm.nih.gov/pubmed/34551122 http://dx.doi.org/10.1002/cpt.2425 |
Ejemplares similares
-
Efficacy and Effectiveness Too Trials: Clinical Trial Designs to Generate Evidence on Efficacy and on Effectiveness in Wide Practice
por: Selker, Harry P., et al.
Publicado: (2019) -
A Proposal for Integrated Efficacy-to-Effectiveness (E2E) Clinical Trials
por: Selker, H P, et al.
Publicado: (2014) -
Sharing data among clinical trials of therapeutics in COVID-19: Barriers and facilitators to collaborating in a crisis
por: Palm, Marisha E., et al.
Publicado: (2021) -
Precision Reimbursement for Precision Medicine: Using Real‐World Evidence to Evolve From Trial‐and‐Project to Track‐and‐Pay to Learn‐and‐Predict
por: Eichler, Hans‐Georg, et al.
Publicado: (2021) -
The use of N-of-1 trials to generate real-world evidence for optimal treatment of individuals and populations
por: Selker, Harry P., et al.
Publicado: (2023)